Multidisciplinary Head and Neck Cancers Symposium

This program has already taken place.

This was a practical and clinically relevant meeting for the entire head and neck cancer community that provided the most up-to-date information on multidisciplinary therapies, the latest clinical research, new treatment strategies, supportive care, scientific breakthroughs and toxicity mitigation.

SITC designated Course Director for the session, Robert Ferris, MD, PhD, FACS, moderated, "Immunotherapy Advances in Head and Neck Cancer," on Saturday, February 17, 2018 from 8 - 9:30 a.m. MT.

Other Highlights included:

• Keynote speakers addressed timely and relevant topics in head and neck cancer treatment.
• Dynamic sessions focused on the major disease sites and expert faculty provided education.
• The top research was presented in oral abstract sessions and a poster reception.
• Interactive and case-based tumor boards.
• There were many opportunities to network with colleagues from around the world.